Bengaluru-based Avesthagen Limited has launched AVGEN Diagnostics, the first entirely incorporated end-to-end bespoke genetic testing service. The innovative platform employs the most recent in next-generation sequencing (NGS) technology and artificial intelligence (AI) driven accuracy analytics that compel diagnostic testing services at B2C, B2B levels forging collaborations with hospitals, private clinics and health insurers.

The selection addresses Cancers, Cardiac Care Diagnostics, Neurodegenerative conditions, Autoimmune conditions, Rare diseases, pharmacogenomics, ancestry analysis and a unique set of tests for women’s health – reproductive genomics and fertility testing, Carrier Screening, and Pre-Natal Diagnostics powered by Congenica, UK a digital health company, that enables precision medicine through its AI-powered diagnostic decision support platform for genomic data. As reported by Bio Spectrum India.

Original Source: MedTechAsia